新型降脂药物阿托伐他汀

The lipid-lowering effects of atorvastatin, a new HMG-CoA reductase inhibitor: results of a randomized, double-masked study[J] . Therese M. Heinonen,Evan Stein,Stuart R. Weiss,James M. McKenney,Michael Davidson,Linda Shurzinske,Donald M. Black.Clinical Therapeutics . 1996 (5)

Plasma mevalonic acid, an index of cholesterol synthesis in vivo, and responsiveness to HMG-CoA reductase inhibitors in familial hypercholesterolaemia[J] . R.P. Naoumova,A.D. Marais,J. Mountney,J.C. Firth,N.B. Rendell,G.W. Taylor,G.R. Thompson.Atherosclerosis . 1996 (2)

Atorvastatin monotherapy and combination therapy in the treatment of severe hypercholesterolemia[J] . T. Heinonen,D. Black.Atherosclerosis . 1995

The lipid-lowering effects of atorvastatin, a new HMG-CoA reductase inhibitor: results of a randomized, double-masked study[J] . Therese M. Heinonen,Evan Stein,Stuart R. Weiss,James M. McKenney,Michael Davidson,Linda Shurzinske,Donald M. Black.Clinical Therapeutics . 1996 (5)

Plasma mevalonic acid, an index of cholesterol synthesis in vivo, and responsiveness to HMG-CoA reductase inhibitors in familial hypercholesterolaemia[J] . R.P. Naoumova,A.D. Marais,J. Mountney,J.C. Firth,N.B. Rendell,G.W. Taylor,G.R. Thompson.Atherosclerosis . 1996 (2)

Atorvastatin monotherapy and combination therapy in the treatment of severe hypercholesterolemia[J] . T. Heinonen,D. Black.Atherosclerosis . 1995